Author:
Syrogiannopoulos G. A.,Silva Chibante A. M.,Gatzola M.,Toporovski J.,Madrid B.,Farhat C. K.,Fall M.,Burgio G. R.,Likitnukul S.,Kissling M.
Publisher
Springer Science and Business Media LLC
Subject
Pharmacology (medical),General Medicine,Pharmacology (medical)
Reference14 articles.
1. Leowski J. Mortality from acute respiratory infection in children under 5 years of age: global estimates. World Health Stat Q 1986; 39c: 138–44
2. Shann F. Etiology of severe pneumonia in children in developing countries. Pediatr Infect Dis J 1986; 5: 247–52
3. Harari M, Shann F, Spooner V, et al. Clinical signs of pneumonia in children. Lancet 1991; 338: 928–30
4. Cullmann E, Edwards DJ, Kissling M, et al. Cefetamet pivoxil: a review of its microbiology, toxicology, pharmacokinetics and clinical efficacy. Int J Antimicrob Agents 1992; 1: 175–92
5. Kitzis MD, Lissine N, Ferre B, et al. In vitro activities of 15 oral beta-lactames against Klebsiella pneumoniae harboring new extended spectrum beta-lactamases. Antimicrob Agents Chemother 1990; 34(9): 1783–6